Cargando…
EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide
Accumulating evidence suggests that glioma stem cells (GSCs), which are rare cells characterized by pluripotency and self-renewal ability, are responsible for glioblastoma (GBM) propagation, recurrence and resistance to therapies. Bone morphogenic proteins (BMPs) induce GSC differentiation, which le...
Autores principales: | Ciechomska, Iwona Anna, Gielniewski, Bartlomiej, Wojtas, Bartosz, Kaminska, Bozena, Mieczkowski, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080762/ https://www.ncbi.nlm.nih.gov/pubmed/32788653 http://dx.doi.org/10.1038/s12276-020-0479-9 |
Ejemplares similares
-
BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells
por: Ciechomska, Iwona Anna, et al.
Publicado: (2016) -
Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
por: Ciechomska, Iwona Anna, et al.
Publicado: (2018) -
In Search for Reliable Markers of Glioma-Induced Polarization of Microglia
por: Walentynowicz, Kacper A., et al.
Publicado: (2018) -
ECOA-6. Genomic and transcriptomic analyses reveal diverse mechanisms responsible for deregulation of epigenetic enzyme/modifier expression in glioblastoma
por: Maleszewska, Marta, et al.
Publicado: (2021) -
Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
por: Kaminska, Bozena, et al.
Publicado: (2019)